Clinical Trials Logo
  1. Home
  2. Breast Cancer
  3. NCT01931644
  4. Details
NCT01931644 Clinical Trial

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Breast Cancer Clinical Trial

Official title:
A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01931644
Other study ID # SAN-BB-01
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 2013
Est. completion date April 2024

Study information
Verified date April 2024
Source Sanguine Biosciences
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research. We make it easy for patients to contribute to research for medical conditions that matter most to them, regardless of their location or ability to travel.

Description:

This study will collect blood and other optionally donated tissue samples from people with all different types of health conditions, as well as healthy control samples, in order to provide biomedical researchers with quality biospecimens that are necessary in translating basic science research into clinically relevant information and technology.

Recruitment information / eligibility
Status Completed
Enrollment 17667
Est. completion date April 2024
Est. primary completion date April 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: - All adults 18-100 years old - Able to provide proof of diagnosis - Live in USA Exclusion Criteria: - Younger than 18 years old - Receipt of blood products within 30 days of study blood collection - Receipt of investigational drug within 30 days of study blood collection

Study Design

Related Conditions & MeSH terms

  • Acquired Immunodeficiency Syndrome
  • ADD/ADHD
  • All Diagnosed Health Conditions
  • Alopecia
  • Alopecia Areata
  • Anemia, Sickle Cell
  • Ankylosing Spondylitis
  • Anxiety Disorders
  • Arthritis
  • Arthritis, Psoriatic
  • Asthma
  • Atopic Dermatitis Eczema
  • Atrophy
  • Beta Thalassemia
  • beta-Thalassemia
  • Bipolar Disorder
  • Breast Cancer
  • Carcinoma, Renal Cell
  • Celiac Disease
  • Cervical Cancer
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Chronic Kidney Diseases
  • Chronic Obstructive Pulmonary Disease
  • Colitis
  • Colitis, Ulcerative
  • Colon Cancer
  • Colonic Neoplasms
  • Colorectal Cancer
  • Colorectal Neoplasms
  • Crohn Disease
  • Crohn's Disease
  • Cystic Fibrosis
  • Depression
  • Dermatitis
  • Dermatitis, Atopic
  • Diabetes Mellitus
  • Disease
  • Down Syndrome
  • Duchenne Muscular Dystrophy
  • Eczema
  • Endometriosis
  • Epilepsy
  • Facioscapulohumeral Muscular Dystrophy
  • Fibrosis
  • G6PD Deficiency
  • General Anxiety Disorder
  • Glucosephosphate Dehydrogenase Deficiency
  • Hepatitis
  • Hepatitis B
  • Hereditary Hemorrhagic Telangiectasia
  • HIV Infections
  • HIV/AIDS
  • Human Papilloma Virus
  • Huntington Disease
  • Huntington's Disease
  • Idiopathic Thrombocytopenic Purpura
  • Insomnia
  • Kidney Cancer
  • Kidney Diseases
  • Kidney Neoplasms
  • Leukemia
  • Lung Cancer
  • Lung Diseases
  • Lung Diseases, Obstructive
  • Lupus Erythematosus, Systemic
  • Lupus Nephritis
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Multiple Sclerosis
  • Muscular Atrophy
  • Muscular Atrophy, Spinal
  • Muscular Dystrophies
  • Muscular Dystrophy, Duchenne
  • Muscular Dystrophy, Facioscapulohumeral
  • Myositis
  • Myotonic Dystrophy
  • Nephritis
  • Ovarian Cancer
  • Ovarian Neoplasms
  • Pancreatic Cancer
  • Pancreatic Neoplasms
  • Papilloma
  • Parkinson Disease
  • Parkinson's Disease
  • Polycystic Kidney Diseases
  • Polyneuropathies
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  • Prostate Cancer
  • Prostatic Neoplasms
  • Psoriasis
  • Psoriatic Arthritis
  • Pulmonary Disease, Chronic Obstructive
  • Purpura
  • Purpura, Thrombocytopenic
  • Purpura, Thrombocytopenic, Idiopathic
  • Purpura, Thrombotic Thrombocytopenic
  • Renal Insufficiency, Chronic
  • Rosacea
  • Scleroderma
  • Scleroderma, Diffuse
  • Scleroderma, Systemic
  • Sclerosis
  • Sickle Cell Anemia
  • Sickle Cell Trait
  • Sjogren's Syndrome
  • Skin Cancer
  • Skin Neoplasms
  • Spinal Muscular Atrophy
  • Spondylarthritis
  • Spondylitis
  • Spondylitis, Ankylosing
  • Systemic Lupus Erythematosus
  • Telangiectasia, Hereditary Hemorrhagic
  • Telangiectasis
  • Thalassemia
  • Thrombotic Thrombocytopenic Purpura
  • Trisomy 21
  • Ulcerative Colitis
  • Uterine Cervical Neoplasms

Locations
Country Name City State
United States Sanguine Biosciences Los Angeles California

Sponsors (1)
Lead Sponsor Collaborator
Sanguine Biosciences

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Biospecimen & Clinical Data Collection To collect enough biospecimens and associated clinical data to allow researchers to come to statistically relevant scientific results 10 years
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2